Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
Zhou TT, Zhao T, Ma F, Zhang YN, Jiang J, Ruan Y, Yan QY, Wang GH, Ren J, Guan XW, Guo J, Zhao YH, Ye JM, Hu LH, Chen J, Shen X.
Zhou TT, et al. Among authors: ma f.
Acta Pharmacol Sin. 2019 Sep;40(9):1193-1204. doi: 10.1038/s41401-018-0208-2. Epub 2019 Mar 4.
Acta Pharmacol Sin. 2019.
PMID: 30833709
Free PMC article.